Subrosa’s Commercialization Platform provides a comprehensive suite of services designed to accelerate the launch of new therapies. This includes global rare disease company network access, patient database utilization, AI-driven patient identification, and strategic partnership facilitation, all aimed at streamlining the go-to-market process and maximizing commercial potential.